Long-term complications from COVID-19 As patients have recovered from severe COVID-19, we are beginning to see some of the long term effects related to the infection. Most patients will recover fully after 2 to 6 weeks, but a small percentage Read More
Emergence of SARS-CoV-2 B.1.1.7. In this CDC publication, the authors discuss the new highly transmissible variant of SARS-CoV-2, B.1.1.7. The report states that B.1.1.7. has the potential to increase the U.S. pandemic trajectory in the coming months. In December 2020, Read More
THE ARTICLE DISCUSSED HAS BEEN RETRACTED. CLICK HERE TO SEE THE RETRACTION NOTICE. A multinational registry analysis found no evidence of benefit of hydroxychloroquine or chloroquine when used either alone or with a macrolide.  Using an international, observational registry across Read More
Among 1438 patients hospitalized with COVID-19 in metropolitan New York in this publication, treatment with hydroxychloroquine, azithromycin, or both was not associated with significantly lower in-hospital mortality. A retrospective study aimed to describe the association between use of hydroxychloroquine, with Read More
This analysis from experts on the ethics of pandemic drug and vaccine research raises significant concerns about promoting the use of unproven off-label uses drugs as part of COVID-19 response efforts. While acknowledging there is limited evidence for its effectiveness, Read More

Get Involved with Indiana CTSI